FGF-23 and sclerostin in serum and bone of CKD patients

Aims: Renal osteodystrophy occurs in the early stages of chronic kidney disease (CKD) and progresses during loss of kidney function. Fibroblast growth factor (FGF)-23 and sclerostin, both produced by osteocytes, are increased in blood of patients with CKD. The aim of this study was to analyze the im...

Descripción completa

Detalles Bibliográficos
Autores principales: Lima, Florence, Monier-Faugere, Marie-Claude, Mawad, Hanna, David, Valentin, Malluche, Hartmut H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dustri-Verlag Dr. Karl Feistle 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10286735/
https://www.ncbi.nlm.nih.gov/pubmed/36970967
http://dx.doi.org/10.5414/CN111111

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10286735/
https://www.ncbi.nlm.nih.gov/pubmed/36970967
http://dx.doi.org/10.5414/CN111111

Ejemplares similares